Skip to main content

Table 6 Transition intensities with hazard ratios for covariates diabetes and hypertension

From: Analyzing COVID-19 progression with Markov multistage models: insights from a Korean cohort

Transition

Baseline transition rate

Hypertension (HR)

Diabetes (HR)

State 1–State 1

 − 0.166

(− 0.18, − 0.153)

  

State 1–State 2

0.166

(0.153,0.18)

1.142

(0.961,1.357)

0.98

(0.794,1.21)

State 1–State 5

1.66e−05

(4.124 e−09,0.067)

0.664

(6.452e−09,6.832e07)

0.803

(1.036e−10,6.223e09)

State 2–State 1

0.046

(0.044,0.049)

1.229

(1.062,1.423)

1.162

(0.966,1.398)

State 2–State 2

 − 0.086

(− 0.09, − 0.082)

  

State 2–State 3

0.04

(0.037,0.042)

1.676

(1.445,1.944)

1.799

(1.518,2.131)

State 2–State 5

3.234e−05

(1.921e−06, 5.444e−04)

0.227

(4.941e−05,1.045e+03

0.4431

(1.427e−05,1.376e+04)

State 3–State 2

0.195

(0.18, 0.212)

1.038

(0.875,1.23)

0.9553

(0.783,1.165)

State 3–State 3

 − 0.208

(− 0.225, − 0.192)

  

State 3–State 4

0.001

(0.008, 0.017)

1.6

(0.881,2.909)

1.8989 (1.023,3.525)

State 3–State 5

7.829e−05

(4.422e−07, 0.013)

2.132

(0.222,2.049e+01)

84.999

(1.882e−01, 3.838e+04)

State 4–State 3

0.223

(0.143, 0.349)

0.722

(0.324,1.609)

1.717

(0.745,3.955)

State 4–State 4

 − 0.227

(− 0.354, − 0.144)

  

State 4–State 5

2.865e−03

(2.396e−05, 0.342)

10.4755

(1.224e−02,8.968e+03)

0.26

(8.642e−05, 7.839e+02)